Sun Pharmaceutical Industries Limited — Important, 14-10-2025: Updates

Sun Pharma, with $6.2 billion revenue, released its ESG Overview. Key highlights: ~21% carbon, 25% water reduction (vs 2020 baseline), 41% renewable energy. R&D spend 6.2%. Zero Class-I recalls, 4 USFDA observations. Sales programs drove 15.1% revenue growth; manager program boosted production efficiency by 9%.